EUVIMEDSkopri EUVIMED
Video/Audio

Mannose Receptor C Type 2 Predicts Poor Outcome in Glioma and is Associated With Invasive Phenotypes and β-Catenin/EMT-related Changes

Yanni Yu, Lijing Ji, Juan Li, Yu Tian, Zhiwen Wang, Yanyang Tu, Haining Zhen, Lei Xu

Journal of Visualized Experiments · 2026

DOI: 10.3791/70882 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Yanni Yu and 7 co-authors. Institution: Medical school Vocational Technical College Yueyang. Major MEDLINE topics: Glioma, beta Catenin, Receptors, Cell Surface, Brain Neoplasms. 43 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Glioma remains a lethal malignancy of the central nervous system, and additional biomarkers that improve prognostic stratification and inform therapeutic exploration are still needed. This study evaluated mannose receptor C-type 2 (MRC2/Endo180) by integrating public transcriptomic cohorts with in vitro validation. Expression profiles and matched clinical annotations were obtained from The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) project for tumor-normal comparisons and pan-cancer screening, and prognostic associations were further examined in the Chinese Glioma Genome Atlas (CGGA) cohort. MRC2 expression was assessed in glioma cell lines by reverse transcription quantitative PCR (RT-qPCR) and immunoblotting, and stable MRC2 knockdown was established in U87 and U251 cells using lentiviral short hairpin RNAs (shRNAs). Cell growth and clonogenicity were evaluated using CCK-8 and colony formation assays, whereas migration and invasion were assessed using porous-membrane insert assays. CDK4, CDK6, and β-catenin/epithelial-mesenchymal transition (EMT)-related markers were analyzed by immunoblotting. Across datasets, MRC2 was elevated in glioma, and higher expression was associated with worse overall survival, disease-specific survival, and progression-free interval. In vitro, MRC2 depletion reduced proliferation, clonogenicity, migration, and invasion, accompanied by decreased CDK4 and CDK6 protein levels and changes in β-catenin and EMT-related markers. Together, these findings support MRC2 as a candidate prognostic biomarker associated with aggressive glioma phenotypes and warrant further mechanistic and in vivo investigation.

Subjects

MeSH terms (MEDLINE)

Gliomabeta CateninReceptors, Cell SurfaceBrain NeoplasmsLectins, C-TypeHumansEpithelial-Mesenchymal TransitionCell Line, TumorPrognosisNeoplasm InvasivenessPhenotypeBiomarkers, TumorMannose Receptor

Substances

beta CateninReceptors, Cell SurfaceLectins, C-TypeBiomarkers, TumorMannose Receptor

Authors and institutions

  • Medical school Vocational Technical College Yueyang.
  • Department of Ultrasound Medicine, Nanfang Hospital, Southern Medical University.
  • Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University.
  • Science Research Center, Huizhou Central People's Hospital; School of Public Health, Benedictine University.
  • Science Research Center, Huizhou Central People's Hospital; tufmmu@188.com.
  • Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University; 13991998909@163.com.

Cite

APA

Yu, Y., Ji, L., Li, J., Tian, Y., Wang, Z., Tu, Y., Zhen, H., & Xu, L. (2026). Mannose Receptor C Type 2 Predicts Poor Outcome in Glioma and is Associated With Invasive Phenotypes and β-Catenin/EMT-related Changes. Journal of Visualized Experiments. https://doi.org/10.3791/70882

Vancouver

Yu Y, Ji L, Li J, Tian Y, Wang Z, Tu Y, et al. Mannose Receptor C Type 2 Predicts Poor Outcome in Glioma and is Associated With Invasive Phenotypes and β-Catenin/EMT-related Changes. Journal of Visualized Experiments. 2026. doi:10.3791/70882

BibTeX
@article{Yu2026,
  author = {Yu, Yanni and Ji, Lijing and Li, Juan and Tian, Yu and Wang, Zhiwen and Tu, Yanyang and Zhen, Haining and Xu, Lei},
  title = {Mannose Receptor C Type 2 Predicts Poor Outcome in Glioma and is Associated With Invasive Phenotypes and β-Catenin/EMT-related Changes},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70882}
}
Start for free →